Document is current
Any future updates will be listed below
-
Authors
Paller, Amy S. https://orcid.org/0000-0001-6187-6549
Marcoux, Danielle
Ramien, Michele
Baselga, Eulalia
de Carvalho, Vania Oliveira
Ardusso, Ledit R. F.
de Graaf, Marlies
Pasmans, Suzanne
Toledo-Bahena, Mirna
Rubin, Cory J.
Joyce, Joel C.
Lee, Lara Wine
Gupta, Rajan
Adams, Bryan
Ardeleanu, Marius
Zhang, Annie
-
Funding
Funding for this research was provided by:
Sanofi
Regeneron Pharmaceuticals
- License Information
-
More Information
Article History
Received: 21 October 2025
Accepted: 3 March 2026
First Online: 17 April 2026
Declarations
:
: Please see the original article for full author disclosures. Eulalia Baselga is a speaker for Almirall; Sanofi; Isdin; Viatris; an investigator for AbbVie, Eli Lilly, Galderma, Incyte, LEO pharma, Pfizer and Sanofi; an investigator and consultant for Pierre Fabre Dermatologie; a consultant for Regeneron Pharmaceuticals Inc. and Sanofi. Lara Wine Lee is an advisory board member for Castle Creek Biosciences, Chiesi, Eli Lilly, Pfizer, Verrica, Regeneron Pharmaceuticals Inc and Twi Biotechnology; is a consultant for AbbVie, Apogee, Amryt Pharma, Chiesi, Eli Lilly Kimberly-Clark, Krystal Biotech, and Novartis; an investigator with AbbVie, Amgen, Amryt Pharma, Arcutis Biotherapeutics, Apogee, Boehringer Ingelheim, Castle Creek Biosciences, Celgene, Eli Lilly, Galderma, Incyte, LEO Pharma, Mayne Pharma, Novartis, Pfizer, Regeneron Pharmaceuticals Inc., Sanofi, Target Pharma, Trevi Therapeutics, TWi Biotechnology, and UCB; and a speaker for Amryt Pharma, Chiesi, Krystal Biotech, and Sanofi, and participates on data safety monitoring boards for BMS.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Please see the referenced article for ethics relating to the original study.
: Not applicable.
: Not applicable.
: Not applicable.
